Dr. Maria Alejandra Valenzuela Arellano, MD

Dr. Valenzuela Arellano practices at University Hospital (MU Health Care) in Columbia, Missouri.

Dr. Valenzuela Arellano's NPI, 1568761955, was assigned on March 24, 2011. Dr. Valenzuela Arellano holds Missouri license 2024049193.

Dr. Valenzuela Arellano's primary practice is University Hospital (MU Health Care), at 1 Hospital Dr, Columbia, MO 65201 in Boone County. The practice phone is (573) 882-4141.

Dr. Valenzuela Arellano's primary practice is University Hospital (MU Health Care) in Columbia, Missouri. Dr. Valenzuela Arellano is also affiliated with University Hospital. The medical group on file is University of Missouri Health Care. Dmand AI also links Dr. Valenzuela Arellano to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valenzuela Arellano practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Valenzuela Arellano's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Valenzuela Arellano is licensed in Missouri.

CMS data shows 803 Medicare services from Dr. Valenzuela Arellano across 11 procedure codes in 2024, for 385 Medicare patients. Medicare paid $35,756 for them. Every service was in an office.

CMS counts 385 Medicare patients who saw Dr. Valenzuela Arellano in 2024. The largest group is 75 to 84, with 170 patients. 69% of them have high cholesterol, and 62% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Valenzuela Arellano's median patient age at 74, with 61% women.

In 2024, Dr. Valenzuela Arellano wrote 308 Medicare Part D claims for 186 patients. 51% of them were for generic drugs. CMS names the drug for 249 of them, across 7 drugs with 11 or more claims each, at $36,658 in total drug cost. In 2023, CMS named 288 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Valenzuela Arellano for performance year 2024, reported as part of a group. Dr. Valenzuela Arellano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 10 general payments to Dr. Valenzuela Arellano from 7 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Horizon Pharma plc paid the most, $211.